NVZMY
Novozymes A/S
Other OTC
People also watch:NVZMFSGSOYLRLCYCFRUYDYAI
48.990.22 (0.46%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close48.76
Open48.79
Bid0.00 x
Ask0.00 x
52wk Range37.98 - 53.21
Day's Range48.79 - 49.10
Volume24,750
Avg Vol (3m)14,541
As of 3:59 PM EDT. Market closed.
  • Capital Cube26 days ago

    ETF’s with exposure to Novozymes A/S : June 30, 2016

    Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to Novozymes A/SHere are 5 ETF’s with the largest exposure to NVZMY-US. Comparing the performance and risk of Novozymes A/S with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns […] (Read more...) The post ETF’s with exposure to Novozymes A/S : June 30, 2016 appeared first on CapitalCube.

  • Novozymes A/S :NVZMY-US: Earnings Analysis: Q1, 2016 By the Numbers : June 3, 2016
    Capital Cube2 months ago

    Novozymes A/S :NVZMY-US: Earnings Analysis: Q1, 2016 By the Numbers : June 3, 2016

    Click here to see latest analysisNovozymes A/S reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Novozymes A/S – Innophos Holdings, Inc., Codexis, Inc., Procter & Gamble Company and E. I. du Pont de Nemours and Company (IPHS-US, CDXS-US, PG-US and DD-US) that have also […] (Read more...) The post Novozymes A/S :NVZMY-US: Earnings Analysis: Q1, 2016 By the Numbers : June 3, 2016 appeared first on CapitalCube.